New Hampshire Trust Novo Nordisk A S Transaction History
New Hampshire Trust
- $475 Billion
- Q4 2024
A detailed history of New Hampshire Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, New Hampshire Trust holds 2,400 shares of NVO stock, worth $194,640. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,400
Previous 2,530
5.14%
Holding current value
$194,640
Previous $301 Million
31.47%
% of portfolio
0.04%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,908Shares Held
317MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC19.9MShares$1.62 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.17 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.16 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.08 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$991 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...